Gantz: Israeli Generals Seek Peace the Most

Benny Gantz | Photo: EPA
Benny Gantz | Photo: EPA
TT

Gantz: Israeli Generals Seek Peace the Most

Benny Gantz | Photo: EPA
Benny Gantz | Photo: EPA

“I spent about 38 years fighting in the Israeli army. And believe me, the generals in the army, who have seen and experienced the horrors of war, are the ones who want peace the most,” said Israel's Defense Minister and Alternate Prime Minister Benny Gantz.

In an interview with Asharq Al-Awsat, Gantz tackled a multitude of questions about peace in the Middle East and revealed that he had already been to a majority of Arab states with clandestine visits as part of his military service and said he would love to go on an official tour.

On the issue of Jerusalem, Gantz stressed that he "believes in the full equality for Arab citizens and their participation in government," and that the city must remain undivided.

He, however, noted that there will be room for a Palestinian capital.

“Jerusalem must stay united, but it will have place for a Palestinian capital,” he said. “It's a vast city, filled with sites that are holy to all of us.”

“We want the Palestinians to have a suitable geographical extension that enables them to lead a comfortable life without obstacles,” he explained.

Gantz also said that he does not see peace in the Middle East without settling the Israeli-Palestinian conflict first. The centrist leader added that Israel will not withdraw to pre-1967 borders but the sides can reach a compromise.

Speaking on the subject of peacemaking and normalization of ties between Israel and the UAE, Bahrain, Sudan, and Morocco, Gantz said that the Palestinians must remain actively involved.

"I want Palestinians to be part of the peace process. The push for normalization within the Arab world is a great and real opportunity," he said.

He warned against what he called the "Iranian axis" in the region, saying it posed a threat for both Israel and Arab states and pointing at countries like Syria and Lebanon as examples of its corruptive influence.

These days, Gantz is fighting a bitter battle with Israeli Prime Minister Benjamin Netanyahu that could topple the government and lead to early elections.

Early elections can prove detrimental for the Blue and White centrist party which is led by Gantz.

Despite the ruinous prospects for the party, Gantz is being pressured into rejecting Netanyahu’s conditions and exiting the government.

It is worth noting that the interview with Gantz took place in his office at the Defense Ministry in Tel Aviv and at the height of the tug-of-war going on between him and Netanyahu.

Both, Netanyahu and Gantz were hoping for the other to make concessions before time ran out and they were faced with unwanted early elections.

Gantz, for his part, predicted that the status quo will remain the same given that Netanyahu is showing no willingness whatsoever to settle disputes.

He considered running in the elections a “matter of national responsibility.”

Even though prospects are dim for the Blue and White party, Gantz sounded optimistic about the tables turning.

“Twenty percent of the electorate has not decided how to vote. I believe that we will get a third of them, and that we will take back a portion of the voters who left us,” he noted.

When asked about Israel’s economic and political stability, Gantz said he doesn’t believe that it was in danger.



Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation
TT

Hevolution CEO Discusses Career in Innovation, Medicine, and Business

Dr. Mehmood Khan, CEO of the Hevolution Foundation
Dr. Mehmood Khan, CEO of the Hevolution Foundation

Dr. Mehmood Khan, CEO of the Hevolution Foundation, the largest philanthropy organization funding aging medicine in the world, expressed that receiving Saudi citizenship will boost his scientific and practical capabilities.
He said this new status will help him advance his research, especially in addressing aging.
This comes as part of a recent royal decree granting Saudi citizenship to several notable scholars, doctors, researchers, and innovators.
“Our Chairman, his Royal Highness (Crown Prince Mohammed bin Salman), has very high expectations of our work and the impact we need to do; We were created in part because of his vision,” Khan told Asharq Al-Awsat.
“Living up to the expectations and challenges we get faced with is itself exciting, but it is challenging,” revealed Khan, affirming that Hevolution’s team is “up to that task.”
Khan, who has experience in both corporate and medical fields, told Asharq Al-Awsat that his work across academic, public, and private sectors has been a continuous learning process, with each area enhancing the others.
According to the CEO, these industries are interconnected, and combining their strengths often leads to the best solutions.
This insight inspired the Hevolution initiative, which brings together the scientific community, NGOs, pharmaceutical companies, policymakers, academia, biotech firms, CEOs, and others to promote healthy aging.
Khan highlighted the value of integrating insights from different sectors.
Academia provides detailed research, the public sector offers insights on population health and regulations, and the corporate world brings innovation and efficiency, explained Khan, adding that by merging these perspectives, the world can tackle complex health challenges more effectively.
“We’ve been working through, and are now investing, funding and partnering with over 200 scientists around the world, and over 150 different university labs,” said Khan.
Hevolution uses this integrated approach to advance healthy aging.
This initiative embodies my passion for addressing major challenges and offers a significant opportunity to make a global impact.
Khan talked about the first $400 million commitment Hevolution made in the last 23 months, calling it “unprecedented.”
“There has never been a non-profit organization in the world that has gone from not existing to now becoming the largest philanthropy funding aging biology and medicine in the world,” affirmed Khan.
Khan stressed that work at Hevolution not only pushes scientific boundaries but also promotes cross-sector collaboration to improve global health outcomes.
Since Khan’s early days in medical school, he’s been deeply interested in nutrition and population health, which was an unconventional focus back then. This journey set the foundation for his later work in community health.
Khan’s time as an endocrinology faculty member at the Mayo Clinic was crucial. He led programs on diabetes, endocrine diseases, metabolism, and nutrition, which strengthened his expertise in designing disease prevention systems.
In the private sector, Khan took on a key role at Takeda Pharmaceutical as the global head of R&D, which shaped his approach to innovative healthcare solutions.
At PepsiCo, as Chief Scientific Officer, he learned crucial principles of scale, impact, transformation, and tackling global challenges.
As CEO of Hevolution, Khan uses all his professional experience to advance the foundation’s mission of developing health sciences to address age-related diseases.
Khan serves on the boards of Reckitt Benckiser and the Saudi Research, Development, and Innovation Authority (RDIA).
He is the CEO of Life Biosciences, a member of Saudi Arabia’s biotechnology strategy committee, and the chair of the advanced technology visiting committee at the US National Institute of Standards and Technology (NIST).
Khan told Asharq Al-Awsat that he feels honored to have recently become a Saudi citizen by royal decree, while also holding dual US and UK citizenship. This helps him lead Hevolution effectively and work closely with international partners.
Khan commented on his recent Saudi citizenship, saying that in addition to feeling honored to receive Saudi citizenship by royal decree, alongside other distinguished individuals, this recognition is a great privilege.
Being a Saudi citizen, as per Khan, is a significant milestone and acknowledges the progress in his work in aging science and global health. It also strengthens Khan’s commitment to the work at Hevolution.
Khan noted that this new status enhances his ability to build relationships and collaborate within the Kingdom and internationally. It offers a deeper connection with the local community and better opportunities to engage with policymakers and leaders.
He also said that this recognition boosts Hevolution’s global presence and credibility, making the foundation’s collaborations with international scientists and business leaders stronger. It positions Hevolution as a key player in addressing age-related diseases.
Khan emphasized that this honor reflects the hard work and innovation of Hevolution’s entire team.
The CEO said that it was collective efforts that have made this achievement possible.
Khan also said he is excited to engage more deeply with the scientific and medical community in the Kingdom, adding that his new citizenship helps him contribute to Vision 2030 and the national biotechnology strategy, promoting innovation and attracting top global talent.